CELU vs AMGN: Which Stock is Better?
Side-by-side comparison of Celularity Inc and Amgen Inc in 2026
CELU
Celularity Inc
$1.23
AMGN
Amgen Inc
$355.30
Key Metrics Comparison
| Metric | CELU | AMGN | Winner |
|---|---|---|---|
| Market Cap | $35.76M | $188.34B | AMGN |
| P/E Ratio | N/A | 24.57 | AMGN |
| EPS (TTM) | $N/A | $14.22 | AMGN |
| Revenue Growth | -0.4% | 0.1% | AMGN |
| Gross Margin | 50.6% | 70.8% | AMGN |
Analyze CELU
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CELU or AMGN a better investment?
Comparing CELU and AMGN: Celularity Inc has a market cap of $35.76M while Amgen Inc has $188.34B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CELU and AMGN?
CELU (Celularity Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CELU or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CELU or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.4% for CELU.
Which company is more profitable: CELU or AMGN?
Amgen Inc (AMGN) has higher gross margins at 70.8% compared to 50.6% for CELU.
Which is the larger company: CELU or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $188.34B compared to $35.76M for CELU.
Should I buy CELU or AMGN in 2026?
Both CELU and AMGN have investment merit. CELU trades at $1.23 while AMGN trades at $355.30. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CELU and AMGN stock?
Key differences: Market Cap ($35.76M vs $188.34B), P/E Ratio (N/A vs 24.6x), Revenue Growth (-0.4% vs 0.1%), Gross Margin (50.6% vs 70.8%).